Akt signaling is required for glioblastoma maintenance in vivo

James P Robinson, Matthew W Vanbrocklin, Andrea J McKinney, H Michael Gach, Sheri L Holmen

Research output: Contribution to journalArticlepeer-review


Glioblastoma multiforme (GBM) can be induced in mice through the combined expression of activated forms of KRas and Akt in glial progenitor cells. We have previously demonstrated that KRas is required for the maintenance of these tumors in vivo as inhibition of KRas expression resulted in apoptotic tumor regression and significantly increased survival. To determine the reliance of these tumors on Akt signaling in vivo, we generated a viral vector that allows the expression of Akt to be controlled post-delivery. Survival rates were compared between those animals with continued Akt expression and animals in which expression of Akt was suppressed. Although a fifth of the tumors were refractory to treatment, inhibition of Akt significantly increased the survival of tumor-bearing mice and nearly a fourth of the mice remained in remission four months after the treatment period. These data suggest that Akt is required for glioblastoma maintenance in the context of activated Ras and that loss of Akt expression results in increased survival; therefore, the PI3K/AKT signaling pathway is a viable therapeutic target in this context.

Original languageEnglish (US)
Pages (from-to)155-167
Number of pages13
JournalAmerican Journal of Cancer Research
Issue number2
StatePublished - 2011
Externally publishedYes

PubMed: MeSH publication types

  • Journal Article


Dive into the research topics of 'Akt signaling is required for glioblastoma maintenance in vivo'. Together they form a unique fingerprint.

Cite this